Human medicines affect fish behavior

Credit: Anna Nilsen/LiU Human medicines that act on important signal systems in the brain make fish bolder, shows a new study on three-spined sticklebacks by researchers at Linköping University. The results reinforce that the signal...

Young blood may hold the key to treating age-related diseases

In what sounds like a scene from a science fiction movie, researchers in 2005 stitched together old and young mice so they shared a circulatory system. Youthful blood seemingly rejuvenated many tissues of the...

Alexion to Acquire Achillion for $930M+, Expanding Rare Disease Portfolio

Alexion Pharmaceuticals CEO Ludwig Hantson, PhD Alexion Pharmaceuticals has agreed to acquire Achillion Pharmaceuticals for $930 million-plus, the companies said today, in a deal designed to strengthen the buyer’s portfolio of rare disease treatments based...

GammaDelta Therapeutics Spins Out Cancer Immunotherapy Biotech

The UK biotech GammaDelta Therapeutics has founded Adaptate Biotherapeutics to develop cancer immunotherapies based on antibodies that boost a rare type of immune cell. Adaptate Biotherapeutics is a spin-out of GammaDelta Therapeutics, a London company...

Biotechnology: Europe’s next ‘hot potato’ – EURACTIV

The discussion over the future of biotechnology in Europe heated up after the EU Court ruled in July last year that gene editing should, in principle, fall under the GMO Directive. Several stakeholders and policymakers...

Harnessing plasmonics for precision agriculture worldwide

A Moore Inventor Fellowship is supporting a Duke engineer in her quest to develop a small, inexpensive hyperspectral camera Credit: Jon Stewart, Duke University DURHAM, N.C. — Maiken...

Scientists develop more accurate method to find good targets for cancer immunotherapy

Ludwig Cancer Research scientists have developed a new and more accurate method to identify the molecular signs of cancer likely to be presented to helper T cells, which stimulate and orchestrate the immune response...

German Cancer Virotherapy Biotech Launches with €12M Series A

Abalos Therapeutics launches today with €12M in Series A funding to get the development of its arenavirus-based cancer therapies off the ground. Boehringer Ingelheim Venture Fund and Gründerfonds Ruhr co-led the investment round, with additional...

GE Healthcare, NIBRT Partner on Cell Therapy, Single-Use Bioprocessing

GE Healthcare (GEHC) and Ireland’s National Institute of Bioprocessing Research and Training (NIBRT) are partnering to deliver educational training programs focused on biopharmaceutical and cell therapy development and manufacturing, building on a two-year-old collaboration. GE...

Global Agricultural Biotechnology Market Share to Hit USD 67.01 Billion By 2025 – News...

The “Agricultural Biotechnology Market by Type (Molecular Diagnostics, Molecular Markers, Tissue Culture, Vaccines, Genetic Engineering, and Others) and by Application (Transgenic Crops, Synthetic Biology-Enables Products, and Others): Global Industry Perspective, Comprehensive Analysis, and Forecast,...